The expression of multidrug resistance-associated protein (MRP) in pancreatic adenocarcinoma cell lines

Donald W. Miller, Michelle Fontain, Carol Kolar, Terence A Lawson

Research output: Contribution to journalArticle

55 Citations (Scopus)

Abstract

The presence of P-glycoprotein (P-gp) and multiple drug resistance-associated protein (MRP) was examined in four human pancreatic adenocarcinoma cell lines (PANC-1, BxPC-3, AsPC-1, and Capan-1). Cellular accumulation of rhodamine 123 and [3H]vincristine were used to determine functional activity of P-gp and MRP, respectively. None of the cells showed any evidence of P-gp in the rhodamine 123 cellular accumulation assays. In contrast, PANC-1, BxPC-3 and AsPC-1 did display an increased accumulation of [3H]vincristine following treatment with either cyclosporin A or verapamil. Western blot analysis confirmed the expression of MRP, and little, if any, measurable P-gp in the cell lysates. These studies suggest that intrinsic drug resistance in pancreatic duct cancer may be due in part to the presence of MRP.

Original languageEnglish (US)
Pages (from-to)301-306
Number of pages6
JournalCancer Letters
Volume107
Issue number2
DOIs
StatePublished - Oct 22 1996

Fingerprint

Multidrug Resistance-Associated Proteins
P-Glycoprotein
Adenocarcinoma
Rhodamine 123
Cell Line
Vincristine
Pancreatic Ducts
Multiple Drug Resistance
Verapamil
Pancreatic Neoplasms
Drug Resistance
Cyclosporine
Western Blotting
Proteins

Keywords

  • Drug resistance
  • MRP
  • P-gp
  • Pancreatic adenocarcinoma

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

The expression of multidrug resistance-associated protein (MRP) in pancreatic adenocarcinoma cell lines. / Miller, Donald W.; Fontain, Michelle; Kolar, Carol; Lawson, Terence A.

In: Cancer Letters, Vol. 107, No. 2, 22.10.1996, p. 301-306.

Research output: Contribution to journalArticle

Miller, Donald W. ; Fontain, Michelle ; Kolar, Carol ; Lawson, Terence A. / The expression of multidrug resistance-associated protein (MRP) in pancreatic adenocarcinoma cell lines. In: Cancer Letters. 1996 ; Vol. 107, No. 2. pp. 301-306.
@article{a904b688324944548e37881b3ad7570a,
title = "The expression of multidrug resistance-associated protein (MRP) in pancreatic adenocarcinoma cell lines",
abstract = "The presence of P-glycoprotein (P-gp) and multiple drug resistance-associated protein (MRP) was examined in four human pancreatic adenocarcinoma cell lines (PANC-1, BxPC-3, AsPC-1, and Capan-1). Cellular accumulation of rhodamine 123 and [3H]vincristine were used to determine functional activity of P-gp and MRP, respectively. None of the cells showed any evidence of P-gp in the rhodamine 123 cellular accumulation assays. In contrast, PANC-1, BxPC-3 and AsPC-1 did display an increased accumulation of [3H]vincristine following treatment with either cyclosporin A or verapamil. Western blot analysis confirmed the expression of MRP, and little, if any, measurable P-gp in the cell lysates. These studies suggest that intrinsic drug resistance in pancreatic duct cancer may be due in part to the presence of MRP.",
keywords = "Drug resistance, MRP, P-gp, Pancreatic adenocarcinoma",
author = "Miller, {Donald W.} and Michelle Fontain and Carol Kolar and Lawson, {Terence A}",
year = "1996",
month = "10",
day = "22",
doi = "10.1016/0304-3835(96)04384-4",
language = "English (US)",
volume = "107",
pages = "301--306",
journal = "Cancer Letters",
issn = "0304-3835",
publisher = "Elsevier Ireland Ltd",
number = "2",

}

TY - JOUR

T1 - The expression of multidrug resistance-associated protein (MRP) in pancreatic adenocarcinoma cell lines

AU - Miller, Donald W.

AU - Fontain, Michelle

AU - Kolar, Carol

AU - Lawson, Terence A

PY - 1996/10/22

Y1 - 1996/10/22

N2 - The presence of P-glycoprotein (P-gp) and multiple drug resistance-associated protein (MRP) was examined in four human pancreatic adenocarcinoma cell lines (PANC-1, BxPC-3, AsPC-1, and Capan-1). Cellular accumulation of rhodamine 123 and [3H]vincristine were used to determine functional activity of P-gp and MRP, respectively. None of the cells showed any evidence of P-gp in the rhodamine 123 cellular accumulation assays. In contrast, PANC-1, BxPC-3 and AsPC-1 did display an increased accumulation of [3H]vincristine following treatment with either cyclosporin A or verapamil. Western blot analysis confirmed the expression of MRP, and little, if any, measurable P-gp in the cell lysates. These studies suggest that intrinsic drug resistance in pancreatic duct cancer may be due in part to the presence of MRP.

AB - The presence of P-glycoprotein (P-gp) and multiple drug resistance-associated protein (MRP) was examined in four human pancreatic adenocarcinoma cell lines (PANC-1, BxPC-3, AsPC-1, and Capan-1). Cellular accumulation of rhodamine 123 and [3H]vincristine were used to determine functional activity of P-gp and MRP, respectively. None of the cells showed any evidence of P-gp in the rhodamine 123 cellular accumulation assays. In contrast, PANC-1, BxPC-3 and AsPC-1 did display an increased accumulation of [3H]vincristine following treatment with either cyclosporin A or verapamil. Western blot analysis confirmed the expression of MRP, and little, if any, measurable P-gp in the cell lysates. These studies suggest that intrinsic drug resistance in pancreatic duct cancer may be due in part to the presence of MRP.

KW - Drug resistance

KW - MRP

KW - P-gp

KW - Pancreatic adenocarcinoma

UR - http://www.scopus.com/inward/record.url?scp=0030598150&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030598150&partnerID=8YFLogxK

U2 - 10.1016/0304-3835(96)04384-4

DO - 10.1016/0304-3835(96)04384-4

M3 - Article

VL - 107

SP - 301

EP - 306

JO - Cancer Letters

JF - Cancer Letters

SN - 0304-3835

IS - 2

ER -